What is the current Price Target for the BriaCell Therapeutics Corp stock?

The average BriaCell Therapeutics Corp target price is $10.97. This is -10.40% lower than the current stock price. The highest price target is -7.77%, the lowest is -11.28%. 3 Analysts have issued a price target BriaCell Therapeutics Corp 2026 .

How high will the BriaCell Therapeutics Corp stock rise?

No reliable answer can be given as to how high the BriaCell Therapeutics Corp stock will rise. The performance of stocks, including the BriaCell Therapeutics Corp stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the BriaCell Therapeutics Corp stock today?

The performance of BriaCell Therapeutics Corp stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the BriaCell Therapeutics Corp stock fall?

The decline in BriaCell Therapeutics Corp stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

BriaCell Therapeutics Corp Forecast, price target & analysts

$12.24

3.16% yesterday

Nasdaq, Dec 04, 10:00 pm CET

ISIN

CA10778Y3023

Symbol

BCTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

BriaCell Therapeutics Corp Target price 2025 - Analyst rating & recommendation

BriaCell Therapeutics Corp Classifications & Recommendation:

Buy

80%

Hold

20%

BriaCell Therapeutics Corp Price Target

Target Price	$10.97
Price	$12.24
Deviation	10.40% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target BriaCell Therapeutics Corp 2026 . The average BriaCell Therapeutics Corp target price is $10.97. This is 10.40% register free of charge lower than the current stock price. The highest price target is $11.29 7.77% register free of charge , the lowest is $10.86 11.28% register free of charge .
	A rating was issued by 5 analysts: 4 Analysts recommend BriaCell Therapeutics Corp to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the BriaCell Therapeutics Corp stock has an average upside potential 2026 of 10.40% register free of charge . Most analysts recommend the BriaCell Therapeutics Corp stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Jul '25	2026 Estimates
Earnings Per Share $	-62.19	-11.56
	42.38%	81.41%
P/E		negative
EV/Sales		0.33

2 Analysts have issued a BriaCell Therapeutics Corp forecast for earnings per share. The average BriaCell Therapeutics Corp EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2025	$-62.19	42.38%
2026	$-11.56 81.41% Unlock
2027	$-3.43 70.33% Unlock
2028	$-1.58 53.94% Unlock
2029	$-0.75 52.53% Unlock

Current	-0.42	73.28%
2026	-1.09 158.60% Unlock
2027	-3.68 237.61% Unlock
2028	-8.02 117.93% Unlock
2029	-16.91 110.85% Unlock

BriaCell Therapeutics Corp...

Current BriaCell Therapeutics Corp Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 27 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 27 2025

Discover more stocks with a high price target

Netflix 1,273.57%

Coinbase Global, Inc. 48.88%

Adidas 48.28%

BioNTech SE - ADR 47.16%

Rheinmetall 45.71%

NIO ADR 42.52%

Deutsche Telekom 41.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now